These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
316 related items for PubMed ID: 23790165
21. Expression of p53, MDM2 protein and Ki-67 antigen in recurrent meningiomas. Ohkoudo M, Sawa H, Hara M, Saruta K, Aiso T, Ohki R, Yamamoto H, Maemura E, Shiina Y, Fujii M, Saito I. J Neurooncol; 1998 May; 38(1):41-9. PubMed ID: 9540056 [Abstract] [Full Text] [Related]
22. An immunohistochemical study of HER2 expression in meningioma and its correlation with tumor grade. Mahzouni P, Movahedipour M. Pathol Res Pract; 2012 Apr 15; 208(4):221-4. PubMed ID: 22420924 [Abstract] [Full Text] [Related]
23. [Expression of HER2/neu in meningiomas: an immunohistochemistry and fluorescence in situ hybridization study]. Wang CL, Mei JH, Wang SS, Xu S, Xu LL, Xiong YF. Zhonghua Bing Li Xue Za Zhi; 2010 Mar 15; 39(3):156-60. PubMed ID: 20450760 [Abstract] [Full Text] [Related]
24. The expression of survivin and Ki-67 in meningiomas: correlation with grade and clinical outcome. Kayaselçuk F, Zorludemir S, Bal N, Erdogan B, Erdogan S, Erman T. J Neurooncol; 2004 Mar 15; 67(1-2):209-14. PubMed ID: 15072469 [Abstract] [Full Text] [Related]
25. Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression. Abdelzaher E, El-Gendi SM, Yehya A, Gowil AG. Br J Neurosurg; 2011 Dec 15; 25(6):707-13. PubMed ID: 20979437 [Abstract] [Full Text] [Related]
26. Detection of progesterone receptor and the correlation with Ki-67 labeling index in meningiomas. Mukherjee S, Ghosh SN, Chatterjee U, Chatterjee S. Neurol India; 2011 Dec 15; 59(6):817-22. PubMed ID: 22234191 [Abstract] [Full Text] [Related]
31. [P53 protein expression and proliferative potential in non-recurrent and recurrent meningiomas]. Miyagami M, Kanou T, Nakamura S. No To Shinkei; 1996 Aug 15; 48(8):719-25. PubMed ID: 8797205 [Abstract] [Full Text] [Related]
33. A study of UbcH10 expression and its association with recurrence of meningiomas. Jiang L, Wang T, Bao Y, Qian J, Wu XJ, Hu GH, Lu YC. J Surg Oncol; 2012 Sep 01; 106(3):327-31. PubMed ID: 22095464 [Abstract] [Full Text] [Related]
35. Expression of E-cadherin and catenins in meningioma: ubiquitous expression and its irrelevance to malignancy. Shimada S, Ishizawa K, Hirose T. Pathol Int; 2005 Jan 01; 55(1):1-7. PubMed ID: 15660696 [Abstract] [Full Text] [Related]
36. Does protein expression predict recurrence of benign World Health Organization grade I meningioma? Kärjä V, Sandell PJ, Kauppinen T, Alafuzoff I. Hum Pathol; 2010 Feb 01; 41(2):199-207. PubMed ID: 19801161 [Abstract] [Full Text] [Related]
38. Automated nuclear segmentation in the determination of the Ki-67 labeling index in meningiomas. Kim YJ, Romeike BF, Uszkoreit J, Feiden W. Clin Neuropathol; 2006 Feb 01; 25(2):67-73. PubMed ID: 16550739 [Abstract] [Full Text] [Related]
39. Na-K-2Cl cotransporter and aquaporin 1 in arachnoid granulations, meningiomas, and meningiomas invading dura. Johnson MD, O'Connell M. Hum Pathol; 2013 Jun 01; 44(6):1118-24. PubMed ID: 23317544 [Abstract] [Full Text] [Related]
40. Correlation of diffusion and perfusion MRI with Ki-67 in high-grade meningiomas. Ginat DT, Mangla R, Yeaney G, Wang HZ. AJR Am J Roentgenol; 2010 Dec 01; 195(6):1391-5. PubMed ID: 21098200 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]